BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Romano F, Garancini M, Uggeri F, Degrate L, Nespoli L, Gianotti L, Nespoli A, Uggeri F. Surgical treatment of liver metastases of gastric cancer: state of the art. World J Surg Oncol. 2012;10:157. [PMID: 22862882 DOI: 10.1186/1477-7819-10-157] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu AW, Yuan P, Li ZY, Tang L, Bu ZD, Ren H, Ji JF. Capecitabine plus paclitaxel induction treatment in gastric cancer patients with liver metastasis: a prospective, uncontrolled, open-label Phase II clinical study. Future Oncol 2016;12:2107-16. [PMID: 27256000 DOI: 10.2217/fon-2016-0145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Sakisaka M, Haruta M, Komohara Y, Umemoto S, Matsumura K, Ikeda T, Takeya M, Inomata Y, Nishimura Y, Senju S. Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-β. J Hepatobiliary Pancreat Sci 2017;24:109-19. [PMID: 28008721 DOI: 10.1002/jhbp.422] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
3 Bala MM, Riemsma RP, Wolff R, Pedziwiatr M, Mitus JW, Storman D, Swierz MJ, Kleijnen J. Cryotherapy for liver metastases. Cochrane Database Syst Rev 2019;7:CD009058. [PMID: 31291464 DOI: 10.1002/14651858.CD009058.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen Y, Yang L, Qin Y, Liu S, Qiao Y, Wan X, Zeng H, Tang X, Liu M, Hou Y. Effects of differential distributed-JUP on the malignancy of gastric cancer. J Adv Res 2021;28:195-208. [PMID: 33364056 DOI: 10.1016/j.jare.2020.06.026] [Reference Citation Analysis]
5 Mastoraki A, Benetou C, Mastoraki S, Papanikolaou IS, Danias N, Smyrniotis V, Arkadopoulos N. The role of surgery in the therapeutic approach of gastric cancer liver metastases. Indian J Gastroenterol 2016;35:331-6. [PMID: 27528456 DOI: 10.1007/s12664-016-0683-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Uggeri F, Pinotti E, Sandini M, Nespoli L, Gianotti L, Romano F. Prognostic Factors Affecting Long-Term Survival after Resection for Noncolorectal, Nonneuroendocrine, and Nonsarcoma Liver Metastases. Gastroenterol Res Pract 2017;2017:5184146. [PMID: 28811821 DOI: 10.1155/2017/5184146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Tapia Rico G, Townsend AR, Klevansky M, Price TJ. Liver metastases resection for gastric and esophageal tumors: is there enough evidence to go down this path? Expert Rev Anticancer Ther. 2016;16:1219-1225. [PMID: 27744727 DOI: 10.1080/14737140.2016.1249858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Uggeri F, Ripamonti L, Pinotti E, Scotti MA, Famularo S, Garancini M, Gianotti L, Braga M, Romano F. Is there a role for treatment-oriented surgery in liver metastases from gastric cancer? World J Clin Oncol 2020; 11(7): 477-494 [PMID: 32821653 DOI: 10.5306/wjco.v11.i7.477] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu WX, Yang L, Yan HM, Yan LN, Zhang XL, Ma N, Tang LM, Gao X, Liu DW. Germline Variants and Genetic Interactions of Several EMT Regulatory Genes Increase the Risk of HBV-Related Hepatocellular Carcinoma. Front Oncol 2021;11:564477. [PMID: 34178612 DOI: 10.3389/fonc.2021.564477] [Reference Citation Analysis]
10 Grimes N, Devlin J, Dunne DF, Poston G, Fenwick S, Malik H. The role of hepatectomy in the management of metastatic gastric adenocarcinoma: a systematic review. Surg Oncol. 2014;23:177-185. [PMID: 25263794 DOI: 10.1016/j.suronc.2014.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
11 Lemke J, Scheele J, Kapapa T, von Karstedt S, Wirtz CR, Henne-Bruns D, Kornmann M. Brain metastases in gastrointestinal cancers: is there a role for surgery? Int J Mol Sci 2014;15:16816-30. [PMID: 25247579 DOI: 10.3390/ijms150916816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
12 Caggiari L, Miolo G, Buonadonna A, Basile D, Santeufemia DA, Cossu A, Palmieri G, De Zorzi M, Fornasarig M, Alessandrini L, Canzonieri V, Lo Re G, Puglisi F, Steffan A, Cannizzaro R, De Re V. Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype. Int J Mol Sci 2017;19:E47. [PMID: 29295527 DOI: 10.3390/ijms19010047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
13 Omari J, Drewes R, Orthmer M, Hass P, Pech M, Powerski M. Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy. Diagn Interv Radiol 2019;25:360-7. [PMID: 31348004 DOI: 10.5152/dir.2019.18390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
14 Santeufemia DA, Lumachi F, Fadda GM, Lo Re G, Miolo G, Basso SM, Chiara GB, Tumolo S. Comment on "repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results": will there be clinical implications in the future? Eur J Radiol 2013;82:1591-2. [PMID: 23642763 DOI: 10.1016/j.ejrad.2013.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Li J, Zhang K, Gao Y, Xi H, Cui J, Liang W, Cai A, Wei B, Chen L. Evaluation of hepatectomy and palliative local treatments for gastric cancer patients with liver metastases: a propensity score matching analysis. Oncotarget 2017;8:61861-75. [PMID: 28977910 DOI: 10.18632/oncotarget.18709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
16 Baghaei K, Hosseinkhan N, Asadzadeh Aghdaei H, Zali MR. Investigation of a common gene expression signature in gastrointestinal cancers using systems biology approaches. Mol BioSyst 2017;13:2277-88. [DOI: 10.1039/c7mb00450h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
17 Zhang Z, Niu B, Chen J, He X, Bao X, Zhu J, Yu H, Li Y. The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer. Biomaterials. 2014;35:4565-4572. [PMID: 24602567 DOI: 10.1016/j.biomaterials.2014.02.024] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
18 Li Q, Zou J, Jia M, Li P, Zhang R, Han J, Huang K, Qiao Y, Xu T, Peng R, Song Q, Fu Z. Palliative Gastrectomy and Survival in Patients With Metastatic Gastric Cancer: A Propensity Score-Matched Analysis of a Large Population-Based Study. Clin Transl Gastroenterol. 2019;10:1-8. [PMID: 31116140 DOI: 10.14309/ctg.0000000000000048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chen L, Song MQ, Lin HZ, Hao LH, Jiang XJ, Li ZY, Chen YX. Chemotherapy and resection for gastric cancer with synchronous liver metastases. World J Gastroenterol 2013; 19(13): 2097-2103 [PMID: 23599631 DOI: 10.3748/wjg.v19.i13.2097] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
20 Sun M, Ding H, Zhu Z, Wang S, Gu X, Xia L, Li T. Identifying Optimal Surgical Intervention-Based Chemotherapy for Gastric Cancer Patients With Liver Metastases. Front Oncol 2021;11:675870. [PMID: 34912701 DOI: 10.3389/fonc.2021.675870] [Reference Citation Analysis]
21 Market M, Baxter KE, Angka L, Kennedy MA, Auer RC. The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction. Cancers (Basel) 2018;11:E2. [PMID: 30577463 DOI: 10.3390/cancers11010002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
22 Yuan J, Wang K, Xi M. MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc. Med Sci Monit 2016;22:617-24. [PMID: 26908019 DOI: 10.12659/msm.897288] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
23 Ceniceros L, Chopitea A, Pardo F, Rotellar F, Arbea L, Sola JJ, Subtil JC, Sangro B, Benito A, Hernández-Lizoain JL, Rodríguez J. Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience. Clin Transl Oncol 2018;20:658-65. [PMID: 29043568 DOI: 10.1007/s12094-017-1767-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Lemke J, Scheele J, Kapapa T, Wirtz CR, Henne-Bruns D, Kornmann M. Brain metastasis in pancreatic cancer. Int J Mol Sci. 2013;14:4163-4173. [PMID: 23429199 DOI: 10.3390/ijms14024163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
25 Martella L, Bertozzi S, Londero AP, Steffan A, De Paoli P, Bertola G. Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015;94:e1113. [PMID: 26252272 DOI: 10.1097/md0000000000001113] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Dong YD, Yuan YL, Yu HB, Tian GJ, Li DY. SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer. Oncol Rep 2019;41:1649-57. [PMID: 30592290 DOI: 10.3892/or.2018.6952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Yuan W, Wang D, Liu Y, Tian D, Wang Y, Zhang R, Yin L, Deng Z. miR‑494 inhibits cell proliferation and metastasis via targeting of CDK6 in osteosarcoma. Mol Med Rep 2017;16:8627-34. [PMID: 28990071 DOI: 10.3892/mmr.2017.7709] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
28 Martella L, Bertozzi S, Londero AP, Steffan A, De Paoli P, Bertola G. Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015;94:e1113. [PMID: 26252272 DOI: 10.1097/md.0000000000001113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
29 Wang W, Liang H, Zhang H, Wang X, Xue Q, Zhang R. Prognostic significance of radical surgical treatment for gastric cancer patients with synchronous liver metastases. Med Oncol. 2014;31:258. [PMID: 25260807 DOI: 10.1007/s12032-014-0258-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]